Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ammirati, E.; Frigerio, M.; Adler, E.D.; Basso, C.; Birnie, D.H.; Brambatti, M.; Friedrich, M.G.; Klingel, K.; Lehtonen, J.; Moslehi, J.J.; et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ. Heart Fail. 2020, 13, e007405. [Google Scholar] [CrossRef]
- Ammirati, E.; Moslehi, J.J. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA 2023, 329, 1098–1113. [Google Scholar] [CrossRef]
- Allen, S.F.; Godley, R.W.; Evron, J.M.; Heider, A.; Nicklas, J.M.; Thomas, M.P. Acute Necrotizing Eosinophilic Myocarditis in a Patient Taking Garcinia Cambogia Extract Successfully Treated with High-Dose Corticosteroids. Can. J. Cardiol. 2014, 30, e13–e15. [Google Scholar] [CrossRef]
- Johnson, D.B.; Balko, J.M.; Compton, M.L.; Chalkias, S.; Gorham, J.; Xu, Y.; Hicks, M.; Puzanov, I.; Alexander, M.R.; Bloomer, T.L.; et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N. Engl. J. Med. 2016, 375, 1749–1755. [Google Scholar] [CrossRef]
- Norwood, T.G.; Westbrook, B.C.; Johnson, D.B.; Litovsky, S.H.; Terry, N.L.; McKee, S.B.; Gertler, A.S.; Moslehi, J.J.; Conry, R.M. Smoldering Myocarditis Following Immune Checkpoint Blockade. J. Immunother. Cancer 2017, 5, 91. [Google Scholar] [CrossRef]
- Champion, S.N.; Stone, J.R. Immune Checkpoint Inhibitor Associated Myocarditis Occurs in Both High-Grade and Low-Grade Forms. Mod. Pathol. 2020, 33, 99–108. [Google Scholar] [CrossRef]
- Tajiri, K.; Aonuma, K.; Sekine, I. Immune Checkpoint Inhibitor-Related Myocarditis. Jpn. J. Clin. Oncol. 2017, 48, 7–12. [Google Scholar] [CrossRef]
- Hang, W.; Chen, C.; Seubert, J.M.; Wang, D.W. Fulminant Myocarditis: A Comprehensive Review from Etiology to Treatments and Outcomes. Signal Transduct. Target. Ther. 2020, 5, 287. [Google Scholar] [CrossRef]
- Wang, D.Y.; Salem, J.-E.; Cohen, J.V.; Chandra, S.; Menzer, C.; Ye, F.; Zhao, S.; Das, S.; Beckermann, K.E.; Ha, L.; et al. Fatal Toxic Effects Associated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. JAMA Oncol. 2018, 4, 1721–1728. [Google Scholar] [CrossRef]
- Moslehi, J.J.; Salem, J.-E.; Sosman, J.A.; Lebrun-Vignes, B.; Johnson, D.B. Increased Reporting of Fatal Immune Checkpoint Inhibitor-Associated Myocarditis. Lancet 2018, 391, 933. [Google Scholar] [CrossRef]
- Pomerantz, B.; O’Rourke, R.A. The Stokes-Adams Syndrome. Am. J. Med. 1969, 46, 941–960. [Google Scholar] [CrossRef]
- Perry, E.L. Corticosteroids in Stokes-Adams Syndrome. Am. Heart J. 1962, 64, 571–572. [Google Scholar] [CrossRef]
- Ribas, A.; Wolchok, J.D. Cancer Immunotherapy Using Checkpoint Blockade. Science 2018, 359, 1350–1355. [Google Scholar] [CrossRef]
- Zotova, L. Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases. Diagnostics 2023, 13, 1243. [Google Scholar] [CrossRef]
- Immunostimulation with Chemotherapy in the Era of Immune Checkpoint Inhibitors—PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/32760014/ (accessed on 17 August 2023).
- Mahmood, S.S.; Fradley, M.G.; Cohen, J.V.; Nohria, A.; Reynolds, K.L.; Heinzerling, L.M.; Sullivan, R.J.; Damrongwatanasuk, R.; Chen, C.L.; Gupta, D.; et al. Myocarditis in Patients Treated with Immune Checkpoint Inhibitors. J. Am. Coll. Cardiol. 2018, 71, 1755–1764. [Google Scholar] [CrossRef]
- Dermani, F.K.; Samadi, P.; Rahmani, G.; Kohlan, A.K.; Najafi, R. PD-1/PD-L1 Immune Checkpoint: Potential Target for Cancer Therapy. J. Cell Physiol. 2019, 234, 1313–1325. [Google Scholar] [CrossRef]
- Yu, Y.; Ma, X.; Zhang, Y.; Zhang, Y.; Ying, J.; Zhang, W.; Zhong, Q.; Zhou, A.; Zeng, Y. Changes in Expression of Multiple Checkpoint Molecules and Infiltration of Tumor Immune Cells after Neoadjuvant Chemotherapy in Gastric Cancer. J. Cancer 2019, 10, 2754–2763. [Google Scholar] [CrossRef]
- Johnston, M.P.; Khakoo, S.I. Immunotherapy for Hepatocellular Carcinoma: Current and Future. World J. Gastroenterol. 2019, 25, 2977–2989. [Google Scholar] [CrossRef]
- Tang, J.; Yu, J.X.; Hubbard-Lucey, V.M.; Neftelinov, S.T.; Hodge, J.P.; Lin, Y. Trial Watch: The Clinical Trial Landscape for PD1/PDL1 Immune Checkpoint Inhibitors. Nat. Rev. Drug Discov. 2018, 17, 854–855. [Google Scholar] [CrossRef]
- Jd, W.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J.J.; Cowey, C.L.; Lao, C.D.; Wagstaff, J.; Schadendorf, D.; Ferrucci, P.F.; et al. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. N. Engl. J. Med. 2017, 377, 1345–1356. [Google Scholar] [CrossRef]
- Jiménez-Alejandre, R.; Ruiz-Fernández, I.; Martín, P. Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis. Cancers 2022, 14, 4494. [Google Scholar] [CrossRef] [PubMed]
- Rroku, A.; Kottwitz, J.; Heidecker, B. Update on Myocarditis—What We Know so Far and Where We May Be Heading. Eur. Heart J. Acute Cardiovasc. Care 2020, 10, 455–467. [Google Scholar] [CrossRef]
- Olejniczak, M.; Schwartz, M.; Webber, E.; Shaffer, A.; Perry, T.E. Viral Myocarditis-Incidence, Diagnosis and Management. J. Cardiothorac. Vasc. Anesth. 2020, 34, 1591–1601. [Google Scholar] [CrossRef] [PubMed]
- Błyszczuk, P. Myocarditis in Humans and in Experimental Animal Models. Front. Cardiovasc. Med. 2019, 6, 64. [Google Scholar] [CrossRef] [PubMed]
- Radovanovic, M.; Petrovic, M.; Barsoum, M.K.; Nordstrom, C.W.; Calvin, A.D.; Dumic, I.; Jevtic, D.; Hanna, R.D. Influenza Myopericarditis and Pericarditis: A Literature Review. J. Clin. Med. 2022, 11, 4123. [Google Scholar] [CrossRef]
- Cannon, H.R.; Bobba, A.; Shekhar, R.; Gangu, K.; Sagheer, S.; Chourasia, P.; Garg, I.; Shuja, H.; Wasty, N.; Sheikh, A.B. Nationwide Analysis of the Clinical Outcomes of Patients Admitted with COVID-19 Infection with Myocarditis and Racial Disparities in Mortality. Curr. Probl. Cardiol. 2023, 48, 101481. [Google Scholar] [CrossRef]
- Witberg, G.; Barda, N.; Hoss, S.; Richter, I.; Wiessman, M.; Aviv, Y.; Grinberg, T.; Auster, O.; Dagan, N.; Balicer, R.D.; et al. Myocarditis after COVID-19 Vaccination in a Large Health Care Organization. N. Engl. J. Med. 2021, 385, 2132–2139. [Google Scholar] [CrossRef]
- Kim, H.W.; Jenista, E.R.; Wendell, D.C.; Azevedo, C.F.; Campbell, M.J.; Darty, S.N.; Parker, M.A.; Kim, R.J. Patients with Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol. 2021, 6, 1196–1201. [Google Scholar] [CrossRef]
- Zornitzki, L.; Havakuk, O.; Rozenbaum, Z.; Viskin, D.; Arbel, Y.; Flint, N.; Arnold, J.; Waissengein, B.; Wolf, I.; Banai, S.; et al. Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis-Same or Different? Life 2022, 12, 1366. [Google Scholar] [CrossRef]
- Radovanovic, M.; Jevtic, D.; Calvin, A.D.; Petrovic, M.; Paulson, M.; Rueda Prada, L.; Sprecher, L.; Savic, I.; Dumic, I. “Heart in DRESS”: Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review. JCM 2022, 11, 704. [Google Scholar] [CrossRef]
- Bonaca, M.P.; Olenchock, B.A.; Salem, J.-E.; Wiviott, S.D.; Ederhy, S.; Cohen, A.; Stewart, G.C.; Choueiri, T.K.; Di Carli, M.; Allenbach, Y.; et al. Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology. Circulation 2019, 140, 80–91. [Google Scholar] [CrossRef] [PubMed]
- Caforio, A.L.P.; Adler, Y.; Agostini, C.; Allanore, Y.; Anastasakis, A.; Arad, M.; Böhm, M.; Charron, P.; Elliott, P.M.; Eriksson, U.; et al. Diagnosis and Management of Myocardial Involvement in Systemic Immune-Mediated Diseases: A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur. Heart J. 2017, 38, 2649–2662. [Google Scholar] [CrossRef]
- Moslehi, J.J.; Brinkley, D.M.; Meijers, W.C. Fulminant Myocarditis: Evolving Diagnosis, Evolving Biology, Evolving Prognosis. J. Am. Coll. Cardiol. 2019, 74, 312–314. [Google Scholar] [CrossRef] [PubMed]
- Baughman, K.L. Diagnosis of Myocarditis: Death of Dallas Criteria. Circulation 2006, 113, 593–595. [Google Scholar] [CrossRef] [PubMed]
- Hu, J.-R.; Florido, R.; Lipson, E.J.; Naidoo, J.; Ardehali, R.; Tocchetti, C.G.; Lyon, A.R.; Padera, R.F.; Johnson, D.B.; Moslehi, J. Cardiovascular Toxicities Associated with Immune Checkpoint Inhibitors. Cardiovasc. Res. 2019, 115, 854–868. [Google Scholar] [CrossRef]
- Escudier, M.; Cautela, J.; Malissen, N.; Ancedy, Y.; Orabona, M.; Pinto, J.; Monestier, S.; Grob, J.-J.; Scemama, U.; Jacquier, A.; et al. Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity. Circulation 2017, 136, 2085–2087. [Google Scholar] [CrossRef]
- Kindermann, I.; Barth, C.; Mahfoud, F.; Ukena, C.; Lenski, M.; Yilmaz, A.; Klingel, K.; Kandolf, R.; Sechtem, U.; Cooper, L.T.; et al. Update on Myocarditis. J. Am. Coll. Cardiol. 2012, 59, 779–792. [Google Scholar] [CrossRef]
- Hauck, A.J.; Kearney, D.L.; Edwards, W.D. Evaluation of Postmortem Endomyocardial Biopsy Specimens from 38 Patients with Lymphocytic Myocarditis: Implications for Role of Sampling Error. Mayo Clin. Proc. 1989, 64, 1235–1245. [Google Scholar] [CrossRef]
- Maisch, B.; Portig, I.; Ristic, A.; Hufnagel, G.; Pankuweit, S. Definition of Inflammatory Cardiomyopathy (Myocarditis): On the Way to Consensus. A Status Report. Herz 2000, 25, 200–209. [Google Scholar] [CrossRef]
- Chen, Y.; Jia, Y.; Liu, Q.; Shen, Y.; Zhu, H.; Dong, X.; Huang, J.; Lu, J.; Yin, Q. Myocarditis Related to Immune Checkpoint Inhibitors Treatment: Two Case Reports and Literature Review. Ann. Palliat. Med. 2021, 10, 8512–8517. [Google Scholar] [CrossRef]
- Jain, V.; Bahia, J.; Mohebtash, M.; Barac, A. Cardiovascular Complications Associated with Novel Cancer Immunotherapies. Curr. Treat. Options Cardiovasc. Med. 2017, 19, 36. [Google Scholar] [CrossRef] [PubMed]
- Zhang, L.; Zlotoff, D.A.; Awadalla, M.; Mahmood, S.S.; Nohria, A.; Hassan, M.Z.O.; Thuny, F.; Zubiri, L.; Chen, C.L.; Sullivan, R.J.; et al. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis. Circulation 2020, 141, 2031–2034. [Google Scholar] [CrossRef] [PubMed]
- Ganatra, S.; Neilan, T.G. Immune Checkpoint Inhibitor-Associated Myocarditis. Oncologist 2018, 23, 879–886. [Google Scholar] [CrossRef] [PubMed]
- Dal’bo, N.; Patel, R.; Parikh, R.; Shah, S.P.; Guha, A.; Dani, S.S.; Ganatra, S. Cardiotoxicity of Contemporary Anticancer Immunotherapy. Curr. Treat. Options Cardiovasc. Med. 2020, 22, 62. [Google Scholar] [CrossRef]
- Hori, T.; Iida, M.; Uchiyama, M.; Shimokawa, T. Successful Cases of Percutaneous Left Ventricular Assist Device “Impella” to Fulminant Myocarditis. J. Cardiothorac. Surg. 2022, 17, 72. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Liu, X.; Zeng, Z.; Cao, J.; Li, X.; Muhetaer, M.; Jin, Z.; Cai, H.; Lu, Z. Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review. J. Cardiovasc. Dev. Dis. 2023, 10, 422. https://doi.org/10.3390/jcdd10100422
Liu X, Zeng Z, Cao J, Li X, Muhetaer M, Jin Z, Cai H, Lu Z. Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review. Journal of Cardiovascular Development and Disease. 2023; 10(10):422. https://doi.org/10.3390/jcdd10100422
Chicago/Turabian StyleLiu, Xin, Ziyue Zeng, Jianlei Cao, Xianqing Li, Muheremu Muhetaer, Zhili Jin, Huanhuan Cai, and Zhibing Lu. 2023. "Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review" Journal of Cardiovascular Development and Disease 10, no. 10: 422. https://doi.org/10.3390/jcdd10100422